Insulin Resistance Study

Paused · Not applicable

Conditions studied: Insulin Resistance, Metabolic Syndrome x

In brief

The purpose of this study is to evaluate how often patients with hepatitis C infection have abnormalities of sugar and fat utilization. Additionally we would like to find out if these abnormalities of sugar and fat utilization are common in other liver diseases, or related to being overweight.

Key facts

Study ID

NCT00614757

Run by

Midwest Biomedical Research

People needed

121

Starts

2005-05-01

Expected to finish

2013-12-01

Last updated by the study team

2012-10-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability to give written consent
• HCV RNA PCR positive for 6 months
• Normal Hgb, WBC,Neutrophils
• Platelets of >/= 65,000
• Direct Bili, within 20% ULN
• Albumin >3
• Serum Creatinine <20% ULN
• TSH WNL
• AFP </= 100

You may not qualify if…

• Women who are pregnant or breast-feeding
• No Thiazolidinedione, Metformin,unless required for the treatment of type II DM
• Hepatitis C of non-genotype 1,2,3
• Any other cause for liver disease other than chronic hepatitis C
• Hemoglobinopathies
• Evidence of advanced liver disease
• Previous organ transplant
• Severe psychiatric disorder
• Significant cardiovascular dysfunction within the past 12 months
• Poorly controlled diabetes mellitus
• Immunologically mediated disease
• Any medical condition requiring chronic systemic administration of steroids
• Evidence of an active or suspected cancer
• Substance abuse at the time of the study
• Known HIV
• Irritability or unwillingness to provide informed consent

Where it is running

• Kansas City VA Medical Center — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.